Tristel plc (GB:TSTL) has released an update.
Tristel plc has been spotlighted at the American Urological Association 2024 conference for its Tristel™ ULT product, a novel high-level disinfectant praised for streamlining urological procedures. The white paper presented emphasizes Tristel™ ULT’s effectiveness against pathogens and its ability to significantly reduce reprocessing time for medical devices, thereby increasing the efficiency of urology practices. Following FDA approval, Tristel has seen growing brand recognition in the US market, with expectations for further progress bolstered by the recent case study.
For further insights into GB:TSTL stock, check out TipRanks’ Stock Analysis page.
